IP Library › Granted Patent US 6,897,220
Granted Patent B2
US 6,897,220 · App. 10/358,556 · Granted May 24, 2005

Inhibitors of histone deacetylase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,897,220
App. No.
10/358,556
Granted
May 24, 2005
Kind
B2
Abstract

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Claims (5)

1. A histone deacetylase inhibitor of formula (1):

or a pharmaceutically acceptable salt thereof.

2. A composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier.

3. A method of inhibiting histone deacetylase in a cell, the method comprising contacting a cell with a compound according to claim 1 , in an amount sufficient to inhibit histone deacetylase.

4. A method of inhibiting histone deacetylase in a cell, the method comprising contacting a cell with a composition according to claim 2 , in an amount sufficient to inhibit histone deacetylase.

Assignments (3)
CHANGE OF NAME Recorded Oct 27, 2010
From: METHYLGENE, INC.
To: 92229129 QUEBEC INC.
Reel/Frame 025200/0827 →
MERGER Recorded Oct 27, 2010
From: 7503547 CANADA INC.
To: METHYLGENE, INC.
Reel/Frame 025201/0647 →
CHANGE OF NAME Recorded Oct 19, 2010
From: 922209129 QUEBEC INC., (FORMERLY "METHYLGENE, INC.")
To: 7503547 CANADA, INC.
Reel/Frame 025159/0476 →